Cromolyn sodium and masitinib combination inhibits fibroblast‐myofibroblast transition and exerts additive cell‐protective and antioxidant effects on a bleomycin‐induced in vitro fibrosis model

Ähnliche Einträge

• Therapeutic potential of agents targeting cannabinoid type 2 receptors in organ fibrosis
  von: Lujain Bader Eddin, et al.
  Veröffentlicht: (2024)
• Synthesis of salcaprozate sodium and its significance in enhancing pancreatic kininogenase absorption performance
  von: Zhong Lv, et al.
  Veröffentlicht: (2024)
• The impact of phosphodiesterase‐5 inhibition or angiotensin‐converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload
  von: Tereza Tykvartova, et al.
  Veröffentlicht: (2024)
• Pharmacokinetics and brain uptake of sodium selenate and selenium in naïve rats and a lateral fluid percussion injury rat model
  von: Chenxu Li, et al.
  Veröffentlicht: (2024)
• The hydroxycarboxylic acid receptor HCA2 is required for the protective effect of ketogenic diet in epilepsy
  von: Jill C. Richardson, et al.
  Veröffentlicht: (2024)